CVE-2026-50034

{"dataType": "CVE_RECORD", "dataVersion": "5.2", "cveMetadata": {"cveId": "CVE-2026-50034", "assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6", "state": "PUBLISHED", "assignerShortName": "icscert", "dateReserved": "2026-06-10T21:21:12.237Z", "datePublished": "2026-06-18T23:47:13.970Z", "dateUpdated": "2026-06-22T14:54:21.615Z"}, "containers": {"cna": {"providerMetadata": {"orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6", "shortName": "icscert", "dateUpdated": "2026-06-18T23:47:13.970Z"}, "title": "Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information", "problemTypes": [{"descriptions": [{"lang": "en", "cweId": "CWE-319", "description": "CWE-319", "type": "CWE"}]}], "affected": [{"vendor": "Apollo Pharmacy", "product": "Blood Glucose Monitoring System (Model No. APG-01 BT)", "versions": [{"status": "affected", "version": "0x0110_v1.1.0"}], "defaultStatus": "unaffected"}], "descriptions": [{"lang": "en", "value": "An attacker within BLE communication range can passively intercept \nwireless traffic and obtain sensitive health-related information, \nincluding glucose measurement values.", "supportingMedia": [{"type": "text/html", "base64": false, "value": "An attacker within BLE communication range can passively intercept \nwireless traffic and obtain sensitive health-related information, \nincluding glucose measurement values."}]}], "references": [{"url": "https://www.apollopharmacy.in/contact-us"}, {"url": "https://www.cisa.gov/news-events/news/understanding-bluetooth-technology"}, {"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01"}, {"url": "https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json"}], "metrics": [{"format": "CVSS", "scenarios": [{"lang": "en", "value": "GENERAL"}], "cvssV3_1": {"version": "3.1", "attackVector": "ADJACENT_NETWORK", "attackComplexity": "LOW", "privilegesRequired": "NONE", "userInteraction": "NONE", "scope": "UNCHANGED", "confidentialityImpact": "HIGH", "integrityImpact": "NONE", "availabilityImpact": "NONE", "baseSeverity": "MEDIUM", "baseScore": 6.5, "vectorString": "CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N"}}, {"format": "CVSS", "scenarios": [{"lang": "en", "value": "GENERAL"}], "cvssV4_0": {"attackVector": "ADJACENT", "attackComplexity": "LOW", "attackRequirements": "NONE", "privilegesRequired": "NONE", "userInteraction": "NONE", "vulnConfidentialityImpact": "HIGH", "subConfidentialityImpact": "NONE", "vulnIntegrityImpact": "NONE", "subIntegrityImpact": "NONE", "vulnAvailabilityImpact": "NONE", "subAvailabilityImpact": "NONE", "exploitMaturity": "NOT_DEFINED", "Safety": "NOT_DEFINED", "Automatable": "NOT_DEFINED", "Recovery": "NOT_DEFINED", "valueDensity": "NOT_DEFINED", "vulnerabilityResponseEffort": "NOT_DEFINED", "providerUrgency": "NOT_DEFINED", "version": "4.0", "baseSeverity": "HIGH", "baseScore": 7.1, "vectorString": "CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N"}}], "workarounds": [{"lang": "en", "value": "Apollo Pharmacy did not respond to CISA's requests to coordinate. \nUsers are encouraged to reach out to Apollo Pharmacy directly for more \ninformation:\n https://www.apollopharmacy.in/contact-us \n\n\n\n\n\nCISA recommends users follow the \nguidance in the Understanding Bluetooth Technology blog:\u00a0\n https://www.cisa.gov/news-events/news/understanding-bluetooth-technology", "supportingMedia": [{"type": "text/html", "base64": false, "value": "<p>Apollo Pharmacy did not respond to CISA's requests to coordinate. \nUsers are encouraged to reach out to Apollo Pharmacy directly for more \ninformation:<br><a href=\"https://www.apollopharmacy.in/contact-us\">https://www.apollopharmacy.in/contact-us</a></p>\n<p><br>CISA recommends users follow the \nguidance in the Understanding Bluetooth Technology blog:&nbsp;<br><a href=\"https://www.cisa.gov/news-events/news/understanding-bluetooth-technology\">https://www.cisa.gov/news-events/news/understanding-bluetooth-technology</a></p>"}]}], "credits": [{"lang": "en", "value": "Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA.", "type": "finder"}], "source": {"advisory": "ICSMA-26-169-01", "discovery": "EXTERNAL"}, "x_generator": {"engine": "Vulnogram 1.0.2"}}, "adp": [{"metrics": [{"other": {"type": "ssvc", "content": {"timestamp": "2026-06-22T14:54:09.331370Z", "id": "CVE-2026-50034", "options": [{"Exploitation": "none"}, {"Automatable": "no"}, {"Technical Impact": "partial"}], "role": "CISA Coordinator", "version": "2.0.3"}}}], "title": "CISA ADP Vulnrichment", "providerMetadata": {"orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0", "shortName": "CISA-ADP", "dateUpdated": "2026-06-22T14:54:21.615Z"}}]}}

{"dataType": "CVE_RECORD", "containers": {"adp": [{"title": "CISA ADP Vulnrichment", "metrics": [{"other": {"type": "ssvc", "content": {"id": "CVE-2026-50034", "role": "CISA Coordinator", "options": [{"Exploitation": "none"}, {"Automatable": "no"}, {"Technical Impact": "partial"}], "version": "2.0.3", "timestamp": "2026-06-22T14:54:09.331370Z"}}}], "providerMetadata": {"orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0", "shortName": "CISA-ADP", "dateUpdated": "2026-06-22T14:54:15.957Z"}}], "cna": {"title": "Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information", "source": {"advisory": "ICSMA-26-169-01", "discovery": "EXTERNAL"}, "credits": [{"lang": "en", "type": "finder", "value": "Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA."}], "metrics": [{"format": "CVSS", "cvssV3_1": {"scope": "UNCHANGED", "version": "3.1", "baseScore": 6.5, "attackVector": "ADJACENT_NETWORK", "baseSeverity": "MEDIUM", "vectorString": "CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N", "integrityImpact": "NONE", "userInteraction": "NONE", "attackComplexity": "LOW", "availabilityImpact": "NONE", "privilegesRequired": "NONE", "confidentialityImpact": "HIGH"}, "scenarios": [{"lang": "en", "value": "GENERAL"}]}, {"format": "CVSS", "cvssV4_0": {"Safety": "NOT_DEFINED", "version": "4.0", "Recovery": "NOT_DEFINED", "baseScore": 7.1, "Automatable": "NOT_DEFINED", "attackVector": "ADJACENT", "baseSeverity": "HIGH", "valueDensity": "NOT_DEFINED", "vectorString": "CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N", "exploitMaturity": "NOT_DEFINED", "providerUrgency": "NOT_DEFINED", "userInteraction": "NONE", "attackComplexity": "LOW", "attackRequirements": "NONE", "privilegesRequired": "NONE", "subIntegrityImpact": "NONE", "vulnIntegrityImpact": "NONE", "subAvailabilityImpact": "NONE", "vulnAvailabilityImpact": "NONE", "subConfidentialityImpact": "NONE", "vulnConfidentialityImpact": "HIGH", "vulnerabilityResponseEffort": "NOT_DEFINED"}, "scenarios": [{"lang": "en", "value": "GENERAL"}]}], "affected": [{"vendor": "Apollo Pharmacy", "product": "Blood Glucose Monitoring System (Model No. APG-01 BT)", "versions": [{"status": "affected", "version": "0x0110_v1.1.0"}], "defaultStatus": "unaffected"}], "references": [{"url": "https://www.apollopharmacy.in/contact-us"}, {"url": "https://www.cisa.gov/news-events/news/understanding-bluetooth-technology"}, {"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01"}, {"url": "https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json"}], "workarounds": [{"lang": "en", "value": "Apollo Pharmacy did not respond to CISA's requests to coordinate. \nUsers are encouraged to reach out to Apollo Pharmacy directly for more \ninformation:\n https://www.apollopharmacy.in/contact-us \n\n\n\n\n\nCISA recommends users follow the \nguidance in the Understanding Bluetooth Technology blog:\u00a0\n https://www.cisa.gov/news-events/news/understanding-bluetooth-technology", "supportingMedia": [{"type": "text/html", "value": "<p>Apollo Pharmacy did not respond to CISA's requests to coordinate. \nUsers are encouraged to reach out to Apollo Pharmacy directly for more \ninformation:<br><a href=\"https://www.apollopharmacy.in/contact-us\">https://www.apollopharmacy.in/contact-us</a></p>\n<p><br>CISA recommends users follow the \nguidance in the Understanding Bluetooth Technology blog:&nbsp;<br><a href=\"https://www.cisa.gov/news-events/news/understanding-bluetooth-technology\">https://www.cisa.gov/news-events/news/understanding-bluetooth-technology</a></p>", "base64": false}]}], "x_generator": {"engine": "Vulnogram 1.0.2"}, "descriptions": [{"lang": "en", "value": "An attacker within BLE communication range can passively intercept \nwireless traffic and obtain sensitive health-related information, \nincluding glucose measurement values.", "supportingMedia": [{"type": "text/html", "value": "An attacker within BLE communication range can passively intercept \nwireless traffic and obtain sensitive health-related information, \nincluding glucose measurement values.", "base64": false}]}], "problemTypes": [{"descriptions": [{"lang": "en", "type": "CWE", "cweId": "CWE-319", "description": "CWE-319"}]}], "providerMetadata": {"orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6", "shortName": "icscert", "dateUpdated": "2026-06-18T23:47:13.970Z"}}}, "cveMetadata": {"cveId": "CVE-2026-50034", "state": "PUBLISHED", "dateUpdated": "2026-06-22T14:54:21.615Z", "dateReserved": "2026-06-10T21:21:12.237Z", "assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6", "datePublished": "2026-06-18T23:47:13.970Z", "assignerShortName": "icscert"}, "dataVersion": "5.2"}

{"affected": [{"affectedData": [{"defaultStatus": "unaffected", "product": "Blood Glucose Monitoring System (Model No. APG-01 BT)", "vendor": "Apollo Pharmacy", "versions": [{"status": "affected", "version": "0x0110_v1.1.0"}]}], "source": "ics-cert@hq.dhs.gov"}], "cveTags": [], "descriptions": [{"lang": "en", "value": "An attacker within BLE communication range can passively intercept \nwireless traffic and obtain sensitive health-related information, \nincluding glucose measurement values."}, {"lang": "es", "value": "Un atacante dentro del rango de comunicaci\u00f3n BLE puede interceptar pasivamente el tr\u00e1fico inal\u00e1mbrico y obtener informaci\u00f3n sensible relacionada con la salud, incluyendo valores de medici\u00f3n de glucosa."}], "id": "CVE-2026-50034", "lastModified": "2026-10-25T23:10:00.167", "metrics": {"cvssMetricV31": [{"cvssData": {"attackComplexity": "LOW", "attackVector": "ADJACENT_NETWORK", "availabilityImpact": "NONE", "baseScore": 6.5, "baseSeverity": "MEDIUM", "confidentialityImpact": "HIGH", "integrityImpact": "NONE", "privilegesRequired": "NONE", "scope": "UNCHANGED", "userInteraction": "NONE", "vectorString": "CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N", "version": "3.1"}, "exploitabilityScore": 2.8, "impactScore": 3.6, "source": "ics-cert@hq.dhs.gov", "type": "Secondary"}], "cvssMetricV40": [{"cvssData": {"Automatable": "NOT_DEFINED", "Recovery": "NOT_DEFINED", "Safety": "NOT_DEFINED", "attackComplexity": "LOW", "attackRequirements": "NONE", "attackVector": "ADJACENT", "availabilityRequirement": "NOT_DEFINED", "baseScore": 7.1, "baseSeverity": "HIGH", "confidentialityRequirement": "NOT_DEFINED", "exploitMaturity": "NOT_DEFINED", "integrityRequirement": "NOT_DEFINED", "modifiedAttackComplexity": "NOT_DEFINED", "modifiedAttackRequirements": "NOT_DEFINED", "modifiedAttackVector": "NOT_DEFINED", "modifiedPrivilegesRequired": "NOT_DEFINED", "modifiedSubAvailabilityImpact": "NOT_DEFINED", "modifiedSubConfidentialityImpact": "NOT_DEFINED", "modifiedSubIntegrityImpact": "NOT_DEFINED", "modifiedUserInteraction": "NOT_DEFINED", "modifiedVulnAvailabilityImpact": "NOT_DEFINED", "modifiedVulnConfidentialityImpact": "NOT_DEFINED", "modifiedVulnIntegrityImpact": "NOT_DEFINED", "privilegesRequired": "NONE", "providerUrgency": "NOT_DEFINED", "subAvailabilityImpact": "NONE", "subConfidentialityImpact": "NONE", "subIntegrityImpact": "NONE", "userInteraction": "NONE", "valueDensity": "NOT_DEFINED", "vectorString": "CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X", "version": "4.0", "vulnAvailabilityImpact": "NONE", "vulnConfidentialityImpact": "HIGH", "vulnIntegrityImpact": "NONE", "vulnerabilityResponseEffort": "NOT_DEFINED"}, "source": "ics-cert@hq.dhs.gov", "type": "Secondary"}], "ssvcV203": [{"source": "134c704f-9b21-4f2e-91b3-4a467353bcc0", "ssvcData": {"id": "CVE-2026-50034", "options": [{"exploitation": "none"}, {"automatable": "no"}, {"technicalImpact": "partial"}], "role": "CISA Coordinator", "timestamp": "2026-06-22T14:54:09.331370Z", "version": "2.0.3"}}]}, "published": "2026-06-19T00:16:47.980", "references": [{"source": "ics-cert@hq.dhs.gov", "url": "https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json"}, {"source": "ics-cert@hq.dhs.gov", "url": "https://www.apollopharmacy.in/contact-us"}, {"source": "ics-cert@hq.dhs.gov", "url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01"}, {"source": "ics-cert@hq.dhs.gov", "url": "https://www.cisa.gov/news-events/news/understanding-bluetooth-technology"}], "sourceIdentifier": "ics-cert@hq.dhs.gov", "vulnStatus": "Awaiting Analysis", "weaknesses": [{"description": [{"lang": "en", "value": "CWE-319"}], "source": "ics-cert@hq.dhs.gov", "type": "Secondary"}]}

{}

{"affected": [{"configurations": [{"platform": null, "status": "affected", "versions": {"scheme": "generic", "value": "0x0110_v1.1.0"}}], "enrichment": {"confidence": 100.0, "confidence_source": "cna", "scores": [{"score": 100.0, "source": "cna"}]}, "original": {"product": "Blood Glucose Monitoring System (Model No. APG-01 BT)", "source": "cna", "vendor": "Apollo Pharmacy"}, "product": "blood_glucose_monitoring_system_(model_no._apg-01_bt)", "vendor": "apollo_pharmacy"}], "created": "2026-06-19T02:00:10.212381+00:00", "updated": "2026-06-20T22:36:34.248702+00:00", "vendors": ["apollo_pharmacy", "apollo_pharmacy$PRODUCT$blood_glucose_monitoring_system_(model_no._apg-01_bt)"]}